Omkar Pharmachem Limited (BOM:532167)
India · Delayed Price · Currency is INR 7.45
-0.12 (-1.59%)
At close: Sep 11, 2026
Omkar Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 2.17 | 1.09 | 0.72 | 1.33 | 2.11 |
Cash & Short-Term Investments | 2.17 | 2.17 | 1.09 | 0.72 | 1.33 | 2.11 |
Cash Growth | 98.63% | 98.63% | 52.79% | -46.04% | -37.23% | 381.55% |
Accounts Receivable | - | 0.32 | 0.97 | 0.49 | 0.49 | - |
Other Receivables | - | 0.51 | 0.59 | 0.59 | - | - |
Receivables | - | 0.83 | 1.56 | 1.07 | 0.49 | - |
Other Current Assets | - | 0.01 | - | 0.05 | 0.81 | 0.81 |
Total Current Assets | - | 3.01 | 2.65 | 1.84 | 2.62 | 2.92 |
Property, Plant & Equipment | - | 0.03 | 0.06 | 0.07 | 0.04 | 0.06 |
Long-Term Investments | - | 363.84 | 93 | 93 | 93 | 93 |
Other Intangible Assets | - | 0.01 | 0.01 | 0.02 | - | - |
Long-Term Deferred Tax Assets | - | 0.01 | 0.31 | 1 | 1.64 | 2.31 |
Total Assets | - | 366.9 | 96.03 | 95.92 | 97.3 | 98.29 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 0.17 | 0.15 | 0.14 | - | - |
Accrued Expenses | - | 0.12 | 0.22 | 0.36 | 0.59 | 0.49 |
Short-Term Debt | - | - | 1.19 | 3.03 | 6.21 | 9.3 |
Current Income Taxes Payable | - | 0.11 | - | - | - | - |
Other Current Liabilities | - | 0.11 | 0.15 | 0.06 | 0.05 | 0.05 |
Total Current Liabilities | - | 0.51 | 1.7 | 3.6 | 6.86 | 9.84 |
Total Liabilities | - | 0.51 | 1.7 | 3.6 | 6.86 | 9.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 100.83 | 100.83 | 100.83 | 100.83 | 100.83 |
Retained Earnings | - | -5.28 | -6.5 | -8.51 | -10.4 | -12.38 |
Comprehensive Income & Other | - | 270.85 | 0 | 0 | 0 | 0 |
Shareholders' Equity | 366.4 | 366.4 | 94.34 | 92.33 | 90.44 | 88.46 |
Total Liabilities & Equity | - | 366.9 | 96.03 | 95.92 | 97.3 | 98.29 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | 1.19 | 3.03 | 6.21 | 9.3 |
Net Cash (Debt) | 2.17 | 2.17 | -0.09 | -2.32 | -4.89 | -7.18 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.22 | 0.22 | -0.01 | -0.23 | -0.48 | -0.71 |
Filing Date Shares Outstanding | 10.1 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
Total Common Shares Outstanding | 10.1 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
Working Capital | - | 2.51 | 0.96 | -1.76 | -4.24 | -6.91 |
Book Value Per Share | - | 36.34 | 9.36 | 9.16 | 8.97 | 8.77 |
Tangible Book Value | 366.4 | 366.39 | 94.33 | 92.31 | 90.44 | 88.46 |
Tangible Book Value Per Share | - | 36.33 | 9.35 | 9.15 | 8.97 | 8.77 |
Machinery | - | 0.31 | 0.31 | 0.27 | 0.2 | 0.2 |